Home › Therapeutic areas › Oncology › Pancreatic Cancer
Pancreatic Cancer (12 companies)
Companies with an active program in Pancreatic Cancer.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ACTU | Actuate Therapeutics | Oncology | 2 | Phase 2 | 7 |
| ALLO | Allogene Therapeutics, Inc. | ImmunologyOncology Rare | 1 | Phase 2 | 12 |
| DRTS | Alpha Tau Medical Ltd. | Oncology | 1 | Phase 2 | 5 |
| RCUS | Arcus Biosciences, Inc. | DermatologyImmunologyOncology | 1 | Phase 3 | 7 |
| ARVN | ARVINAS, INC. | NeurologyOncology Rare | 1 | Approved | 15 |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | Oncology | 2 | Phase 1 | 8 |
| IMRX | Immuneering Corp | Oncology | 1 | Phase 3 | 5 |
| IBRX | ImmunityBio, Inc. | Infectious DiseaseOncology | 2 | Approved | 17 |
| KURA | Kura Oncology, Inc. | MetabolicOncology | 1 | Phase 1 | 9 |
| MRKR | Marker Therapeutics, Inc. | Oncology | 1 | Phase 1 | 4 |
| PMVP | PMV Pharmaceuticals, Inc. | Oncology | 1 | Phase 2 | 7 |
| TNGX | Tango Therapeutics, Inc. | Oncology | 1 | Phase 1 | 6 |
No companies match.